Epidermal growth factor tyrosine kinase inhibitors (EGFR TKIs) and economics.
van Zandwijk
Nico
N
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000191:economics / Q000473:pathology; D017281:Cost of Illness; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005252:Fees, Pharmaceutical; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000191:economics / Q000473:pathology; D010349:Patient Compliance; D047428:Protein Kinase Inhibitors / Q000191:economics* / Q000627:therapeutic use
D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors